FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

922079011000036102: ascorbic acid 250 mg + cupric oxide 1.25 mg + D-alpha-tocopheryl acid succinate 165 mg + zinc (as oxide) 40 mg tablet (medicinal product unit of use)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    980143501000036118 ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module
    980143511000036116 ascorbic acid 250 mg + cupric oxide 1.25 mg + D-alpha-tocopheryl acid succinate 165 mg + zinc (as oxide) 40 mg tablet (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Is a medicinal product unit of use false Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Is a ascorbic acid + cupric oxide + D-alpha-tocopheryl acid succinate + zinc oxide false Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has intended active ingredient ascorbic acid false Inferred relationship Some 1625105118
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has Australian BoSS ascorbic acid false Inferred relationship Some 1625105118
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has intended active ingredient cupric oxide false Inferred relationship Some 1661676898
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has Australian BoSS cupric oxide false Inferred relationship Some 1661676898
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has intended active ingredient d-alpha-tocopheryl acid succinate false Inferred relationship Some 1351022498
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has Australian BoSS d-alpha-tocopheryl acid succinate false Inferred relationship Some 1351022498
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has intended active ingredient zinc oxide false Inferred relationship Some 1808778510
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has Australian BoSS zinc false Inferred relationship Some 1808778510
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has manufactured dose form tablet false Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet has unit of use tablet false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Macu-Vision tablet: film-coated Is a False ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 90 has MPUU False ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 30 has MPUU False ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Inferred relationship Some
    ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet, 150 has MPUU False ascorbic acid 250 mg + cupric oxide 1.25 mg (equivalent to 1 mg of copper) + D-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc (as oxide) 40 mg tablet Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start